CY1110869T1 - Μεθοδος για τον καθαρισμο του εντερου - Google Patents

Μεθοδος για τον καθαρισμο του εντερου

Info

Publication number
CY1110869T1
CY1110869T1 CY20101100988T CY101100988T CY1110869T1 CY 1110869 T1 CY1110869 T1 CY 1110869T1 CY 20101100988 T CY20101100988 T CY 20101100988T CY 101100988 T CY101100988 T CY 101100988T CY 1110869 T1 CY1110869 T1 CY 1110869T1
Authority
CY
Cyprus
Prior art keywords
lavages
volume
laxative
colon
reduced volume
Prior art date
Application number
CY20101100988T
Other languages
English (en)
Inventor
Russell W Pelham
Vivian Caballero
Edmund V Dennett Jr
Bruce H Aronson
Robert M Raleigh Jr
Mark Vb Cleveland
Original Assignee
Braintree Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braintree Laboratories, Inc. filed Critical Braintree Laboratories, Inc.
Publication of CY1110869T1 publication Critical patent/CY1110869T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Vehicle Body Suspensions (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

Διεγερτικό καθαρτικό σε συνδυασμό με ένα οσμωτικό καθαρτικό παράγει έναν ασφαλή και αποτελεσματικό καθαρισμό του εντέρου και του κόλου με έναν μειωμένο όγκο εισαγωγής υγρού. Χορηγώντας εις έναν ασθενή από του στόματος ένα διεγερτικό καθαρτικό, όπως bisacodyl και στην συνέχεια, μετά από ένα βιολογικά καθορισμένο διάστημα, ένα διάλυμα μικρού όγκου PEG εντός ύδατος, καθαρίζονται τα έντερα και το κόλον κατά την προπαρασκευή για διαγνωστική κολονοσκόπηση, χωρίς την ακατάσχετη, ανεξέλεγκτη διάρροια η οποία συνήθως ακολουθεί μια κατάποση ισοτονικών πλύσεων μεγάλου όγκου ή υπερτονικών πλύσεων μικρότερου όγκου.
CY20101100988T 2004-06-04 2010-11-03 Μεθοδος για τον καθαρισμο του εντερου CY1110869T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2004/017610 WO2005120501A1 (en) 2004-06-04 2004-06-04 Method of bowel cleansing
EP04754258A EP1750702B1 (en) 2004-06-04 2004-06-04 Method of bowel cleansing

Publications (1)

Publication Number Publication Date
CY1110869T1 true CY1110869T1 (el) 2015-06-10

Family

ID=34958095

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100988T CY1110869T1 (el) 2004-06-04 2010-11-03 Μεθοδος για τον καθαρισμο του εντερου

Country Status (13)

Country Link
EP (2) EP2281562A3 (el)
JP (1) JP2008501683A (el)
AT (1) ATE476180T1 (el)
AU (1) AU2004320512A1 (el)
CA (1) CA2569178A1 (el)
CY (1) CY1110869T1 (el)
DE (1) DE602004028523D1 (el)
DK (1) DK1750702T3 (el)
ES (1) ES2350391T3 (el)
PL (1) PL1750702T3 (el)
PT (1) PT1750702E (el)
SI (1) SI1750702T1 (el)
WO (1) WO2005120501A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224909D0 (en) 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
WO2009140764A1 (en) * 2008-05-23 2009-11-26 Kingston General Hospital Colon cleansing method and kit
KR20120037931A (ko) * 2009-06-03 2012-04-20 앱탈리스 파마 캐나다 아이엔씨. Ｌ-슈거 장 세척제 및 이의 사용
CN103338768B (zh) 2010-12-13 2019-04-19 萨利克斯药品有限公司 胃和结肠的配制剂及其制备和使用方法
GB201103942D0 (en) * 2011-03-08 2011-04-20 Norgine Bv Compositions
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
RU2473330C1 (ru) * 2011-12-09 2013-01-27 Александр Павлович Погромов Средство для кишечного лаважа
MY174758A (en) 2012-09-11 2020-05-13 Norgine Bv Compositions comprising peg and ascorbate
AU2014227598B2 (en) 2013-03-15 2018-12-06 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
WO2020165658A2 (en) * 2019-02-15 2020-08-20 Seaford Pharmaceuticals Inc. Method to prevent complications associated with bowel cleansing and dosing kit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
ATE235894T1 (de) 1996-05-08 2003-04-15 Craig A Aronchick Nichtwässrige abführmittel für den kolon
EP0872242B1 (en) 1996-11-13 2001-06-06 C.B. Fleet Company, Inc. A coated sodium phosphate bowel cleanser
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations

Also Published As

Publication number Publication date
AU2004320512A1 (en) 2005-12-22
PL1750702T3 (pl) 2011-04-29
EP1750702B1 (en) 2010-08-04
DE602004028523D1 (de) 2010-09-16
DK1750702T3 (da) 2010-11-22
EP2281562A2 (en) 2011-02-09
EP1750702A1 (en) 2007-02-14
WO2005120501A1 (en) 2005-12-22
SI1750702T1 (sl) 2011-03-31
PT1750702E (pt) 2010-11-11
EP2281562A3 (en) 2011-11-23
CA2569178A1 (en) 2005-12-22
JP2008501683A (ja) 2008-01-24
ATE476180T1 (de) 2010-08-15
ES2350391T3 (es) 2011-01-21

Similar Documents

Publication Publication Date Title
CY1110869T1 (el) Μεθοδος για τον καθαρισμο του εντερου
WO2007079000A3 (en) Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy
Madden et al. Inflammation in ileal reservoirs:'pouchitis'.
GB0518804D0 (en) Exudialysis tissue cleanser
DK2292244T3 (da) Saltopløsning til rensning af colon
AR046651A1 (es) Composicion purgante colonica con agente aglutinante soluble
JP6408157B2 (ja) 洗浄用組成物
US20220233437A1 (en) Devices, compositions and methods for colonic microbiome engraftment
CN108529743A (zh) 一种具有双重除污效果的摆动啮合式生活废水处理装置
CN108423810A (zh) 一种具有双重除污效果的曲柄连杆式生活废水处理装置
CN205241406U (zh) 一种游泳池污水臭氧杀菌消毒系统
CN103028160B (zh) 预防医学的肠道洁净装置
MD2354G2 (ro) Metodă de tratament al encefalopatiei hepatice
CN207608429U (zh) 一种简易高效的生活污水过滤消毒处理装置
CN208218585U (zh) 一种快速生产富氢水的矿化装置
CN211188741U (zh) 一种肛肠科用清洗涂药装置
KR100336702B1 (ko) 치아 근관 세척액
RU2249451C2 (ru) Способ лечения острого гнойного воспаления в серозной полости
Kumar et al. Ileal pouch motility
RU2003110484A (ru) Средство для лечения гайморита "антигайморит"
ES2457724A1 (es) Solución fisiológica para la higiene rectal
TSURUOKA Preparation for colonoscopic examination without dietary restriction on the previous day
TH77757B (th) ขนาดของเกลือโนนาโซเดียมของเมธิลโอ-(2,3,4-ไตร-โอ-เมธิล-6-โอ-ซัลโฟ-แอลฟา-ดี-กลูโคพัยราโนซิล)-(14)-โอ-(2,3-ได-โอ-เมธิล-บีตา-ดี-กลูโคพัยราโนซิลยูโรนิกแอซิด)-(14)-โอ-(2,3,6-ไตร-โอ-ซัลโฟ-แอลฟา-ดี-กลูโคพัยราโนซิล)-(14)-โอ-(2,3-ได-โอ-เมธิล-แอลฟา-แอล-ไอโดพัยราโนซิลยูโรนิกแอซิด)-(14)-2,3,6-ไตร-โอ-ซัลโฟ-แอลฟา-ดี-กลูโคพัยราโนไซด์ (ซึ่งต่อไปจะใช้ชื่อย่อว่า " SanOrg34006") สำหรับการรักษาภาวะลิ่มเลือดหลุดอุดหลอดเลือดดำและการป้องกันไม่ให้เกิดครั้งที่สองในผู้ป่วยที่อยู่ในภาวะมีลิ่มเลือดในหลอดเลือดดำที่อยู่ลึก
RU2000108094A (ru) Способ непрямой интестинальной электрохимической детоксикации у больных кишечной непроходимостью
ITMI960521A1 (it) "supposte effervescenti antistipsi."